Walleye Capital LLC Clovis Oncology, Inc. Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $159,320 - $271,320	-28,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $286,520 - $836,000	-76,000 Reduced 73.08%	28,000 $178,000
Q4 2019 Feb 14, 2020	SELL	$3.0 - $16.43 $85,500 - $468,255	-28,500 Reduced 21.51%	104,000 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$3.93 - $15.35 $472,779 - $1.85 Million	120,300 Added 986.07%	132,500 $521,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $156,282 - $313,174	12,200 New	12,200 $181,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.